NTT-DATA
26.2.2024 06:02:29 CET | Business Wire | Press release
NTT DATA, a global leader in IT infrastructure and services, and Schneider Electric, a pioneer in digital transformation for energy management and automation, have unveiled a first-of-a-kind co-innovation that empowers enterprises to harness the power of edge computing. The strategic partnership introduces a unique solution that seamlessly integrates Edge, Private 5G, IOT, and Modular Data Centers, providing unparalleled connectivity, and supports the computational demands of Generative AI applications deployed at the edge.
The joint offering combines NTT DATA’s Edge as a Service, which includes fully managed Edge to Cloud, Private 5G, and IoT capabilities, with Schneider Electric’s EcoStruxure, a modular data center that fuses OT solutions with the latest in IT technologies. This powerful combination enables companies to maximize energy efficiency and meet the demands of compute-intensive tasks such as machine vision, predictive maintenance, and other AI inferencing applications at the edge.
“We've listened to our customers and know that processing vast amounts of data generated by edge devices is where the future of digital transformation lies. That's why we're excited to announce that we have the solution to meet these obstacles and are ready to lead the way towards a more connected and efficient digital world. We are thrilled at the prospect of what our continued collaboration with Schneider Electric means for the industrial and other sectors,” said Shahid Ahmed, EVP New Ventures, and Innovation at NTT Ltd.
Customers can now implement a complete solution, including edge data centers tailored for digital transformation in remote and brownfield locations, where high compute demands critical infrastructure, such as power, cooling, racks, and specialized IoT and AI management systems.
The companies will go to market to address joint customer requirements to meet the growing demand from organizations who are looking to leverage edge compute to support automation and enable data-driven decision making. According to NTT DATA’s Edge Advantage report nearly 70% of enterprises are accelerating edge adoption to solve critical business challenges.
With today’s news, NTT DATA and Schneider Electric announced they are delivering the first Private 5G enabled deployment of an EcoStruxure Data Center at Marienpark Berlin. The historic site will be developed into a leading innovation park. The area spans over 30-hectare, equivalent to 74 acres, and will focus on delivering enhanced connectivity and compute experiences for users across the campus.
“Today’s innovation ecosystems in Marienpark increasingly depend on specific technological infrastructures. Easy-to-access computational power combined with advanced connectivity are a key issue. We need an innovative environment with such an infrastructure to satisfy future user demands of our community,” said Guido Schütte, Managing Director, Marienpark Berlin.
NTT DATA and Schneider Electric initially co-innovated to test the power of Private 5G at Schneider Electric’s Lexington Smart Factory, the first of Schneider Electric’s U.S. plants to become a Smart Factory showcase site leveraging Private 5G, IoT connectivity, edge analytics, and predictive analytics to drive energy efficiency and further sustainability goals.
“After leveraging NTT DATA’s expertise in Private 5G connectivity and then maximizing synergies with our EcoStruxure architecture in our facilities, it’s time to expand our collaboration and bring a complete solution to industrial customers,” said Rob McKernan, President, Cloud & Service Provider Segment at Schneider Electric. “Together, we aim to assist global clients in adopting connected devices, specialized industrial solutions, and the right edge computing infrastructure with modular Data Centers to gain valuable data insights, particularly in the context of IoT and emerging AI requirements.”
The collaboration addresses the challenges brought on by industry 4.0 applications, ensuring seamless connectivity, high bandwidth, and secure low latency connections through Edge data centers.
“Industry 4.0 relies on actionable, data-driven intelligence delivered in real time whether that be in a factory, an industrial park, an airport, or an office campus,“ said Camille Mendler, Chief Analyst, Enterprise Services, Omdia. “AI-enriched data already accounts for a third of enterprise network traffic, but it will dominate digital interactions by 2030. To profit from AI insights, enterprises must invest in digital resources at the edge, and the technology infrastructure that powers it, now.”
Innovations on Display at Mobile World Congress
NTT DATA and Schneider Electric will discuss their co-innovation partnership and demonstrate how edge and private 5G are transforming industries on February 26 between 1300 – 1400 hours at the NTT DATA booth in Hall 4 – Stand 4A20.
About NTT Ltd.
As part of NTT DATA, a USD 30 billion IT services provider, NTT Ltd. is a leading IT infrastructure and services company serving 65% of the Fortune Global 500 and more than 75% of the Fortune Global 100. We lay the foundation for organizations’ edge-to-cloud networking ecosystem, simplify the complexity of their workloads across multicloud environments, and innovate at the edge of their IT environments where networks, cloud and applications converge. We offer tailored infrastructure and ensure consistent best practices in design and operations across all of our secure, scalable and customizable data centers. On the journey towards a software-defined future, we support organizations with our platform-delivered infrastructure services. We enable a connected future.
Visit us at services.global.ntt
About Schneider Electric
Schneider Electric’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On. Our mission is to be your digital partner for Sustainability and Efficiency. We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries. We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values. www.se.com
Follow us on:
X
Facebook
LinkedIn
YouTube
Instagram
Schneider Electric Blog
Discover the newest perspectives shaping sustainability, electricity 4.0, and next-generation automation on Schneider Electric Insights.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223446791/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom